Xinjiang Bai Hua Cun Pharma Tech Co Ltd
SSE:600721
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Merus Power Oyj
OMXH:MERUS
|
FI |
|
China Wuyi Co Ltd
SZSE:000797
|
CN |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (71.5), the stock would be worth ¥10.28 (15% upside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 62.1 | ¥8.92 |
0%
|
| 3-Year Average | 71.5 | ¥10.28 |
+15%
|
| 5-Year Average | 62.1 | ¥8.92 |
0%
|
| Industry Average | 27.4 | ¥3.94 |
-56%
|
| Country Average | 28.8 | ¥4.14 |
-54%
|
Forward EV/EBITDA
Today’s price vs future ebitda
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
|
Xinjiang Bai Hua Cun Pharma Tech Co Ltd
SSE:600721
|
3.4B CNY | 62.1 | 84.3 | |
| ZA |
K
|
Kumba Iron Ore Ltd
JSE:KIO
|
103.8B ZAR | 3.5 | 7.1 | |
| BR |
|
Vale SA
BOVESPA:VALE3
|
383.1B BRL | 5.3 | 27.5 | |
| LU |
|
ArcelorMittal SA
AEX:MT
|
40.3B EUR | 9.5 | 14.7 | |
| AU |
|
Fortescue Metals Group Ltd
ASX:FMG
|
65.4B AUD | 8.1 | 11.9 | |
| AU |
F
|
Fortescue Ltd
XMUN:FVJ
|
39.2B EUR | 8.1 | 12.1 | |
| US |
|
Nucor Corp
NYSE:NUE
|
46.3B USD | 12.2 | 26.6 | |
| IN |
|
JSW Steel Ltd
NSE:JSWSTEEL
|
3T INR | 13.8 | 40.7 | |
| US |
|
Steel Dynamics Inc
NASDAQ:STLD
|
30.6B USD | 16.8 | 25.8 | |
| IN |
|
Tata Steel Ltd
NSE:TATASTEEL
|
2.6T INR | 10.7 | 28.8 | |
| US |
|
Allegheny Technologies Inc
NYSE:ATI
|
22.3B USD | 27.3 | 55.2 |
Market Distribution
| Min | 0 |
| 30th Percentile | 16.3 |
| Median | 28.8 |
| 70th Percentile | 53.1 |
| Max | 49 021 |
Other Multiples
Xinjiang Bai Hua Cun Pharma Tech Co Ltd
Glance View
Xinjiang Baihuacun Pharam Tech Co., Ltd. provides medical research and development services as a contract research organization (CRO). The company is headquartered in Urumqi, Xinjiang and currently employs 722 full-time employees. The firm's main business is the research and development, registration and application of small molecule chemicals and the development of peptide drugs. The firm is engaged in the early discovery and screening of new drugs, drug clinical trials, biological sample analysis, medicine testing services, active pharmaceutical ingredient (API) and intermediate supply. The firm is also engaged in leasing and property services. The firm mainly conducts business within the domestic market.
